Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Treace Medical Concepts Inc has a consensus price target of $13.36 based on the ratings of 8 analysts. The high is $32 issued by SVB Leerink on November 5, 2021. The low is $6 issued by Stifel on May 8, 2024. The 3 most-recent analyst ratings were released by UBS, Truist Securities, and Truist Securities on August 7, 2024, August 7, 2024, and July 16, 2024, respectively. With an average price target of $7.83 between UBS, Truist Securities, and Truist Securities, there's an implied 56.20% upside for Treace Medical Concepts Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Treace Medical Concepts (NASDAQ:TMCI) was reported by UBS on August 7, 2024. The analyst firm set a price target for $7.00 expecting TMCI to rise to within 12 months (a possible 39.58% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for Treace Medical Concepts (NASDAQ:TMCI) was provided by UBS, and Treace Medical Concepts maintained their neutral rating.
The last upgrade for Treace Medical Concepts Inc happened on January 7, 2022 when Morgan Stanley raised their price target to $30. Morgan Stanley previously had an equal-weight for Treace Medical Concepts Inc.
The last downgrade for Treace Medical Concepts Inc happened on May 16, 2024 when UBS changed their price target from $16 to $6.5 for Treace Medical Concepts Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Treace Medical Concepts, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Treace Medical Concepts was filed on August 7, 2024 so you should expect the next rating to be made available sometime around August 7, 2025.
While ratings are subjective and will change, the latest Treace Medical Concepts (TMCI) rating was a maintained with a price target of $6.50 to $7.00. The current price Treace Medical Concepts (TMCI) is trading at is $5.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.